Cargando…
LIMD1‐AS1 suppressed non‐small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U
BACKGROUND: Non‐small cell lung cancer (NSCLC) occupies the majority of lung cancer cases and is notorious for the awful prognosis. LIM domains‐containing 1 (LIMD1) is suggested as a tumor suppressor in lung cancer, but its mechanism in NSCLC remains elusive. Present study aimed to uncover the mecha...
Autores principales: | Pan, Jianyuan, Tang, Yongqin, Liu, Shumei, Li, Lily, Yu, Bo, Lu, Yuanyuan, Wang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286462/ https://www.ncbi.nlm.nih.gov/pubmed/32239804 http://dx.doi.org/10.1002/cam4.2898 |
Ejemplares similares
-
HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2013) -
AJUBA and WTIP can compete with LIMD1 for junctional localization and LATS regulation
por: Kirichenko, Elmira, et al.
Publicado: (2022) -
Upregulation of Biomarker Limd1 Was Correlated with Immune Infiltration in Doxorubicin-Related Cardiotoxicity
por: Zhang, Rui, et al.
Publicado: (2023) -
PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1
por: Foxler, Daniel E., et al.
Publicado: (2011) -
hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene
por: Talukdar, Indrani, et al.
Publicado: (2011)